Brigham and Women's Hospital - Expanded Access Programs

Sponsor Overview

Explore verified public information about Brigham and Women's Hospital's expanded access programs, compassionate use policies, and patient eligibility pathways. This report aggregates official statements, independent research, and regulatory data to help patients, providers, and sponsors collaborate efficiently.

Compliance Score

60^{-20 (hospital)} out of 100

Good

Evidence Library

Unique references curated across 1 content categories.

Clinical Trials

No trials referenced

ClinicalTrials.gov data sources power this status.

Last Verified

2025

Dataset refreshed continuously through Right2Hope ETL pipelines.

Expanded Access Intelligence

EAP Related Articles from Sponsor

Score contribution: 80 — 2 supporting sources.

Score 802 references

Featured Reference

Prevention of Heart and Vascular Disease - Brigham and Women's ...Opens in new window

Through our position in advancing cardiovascular science, we often have early access to medications prior to approval, either through clinical trials or compassionate use.

Emergency Critical Care Research - Brigham and Women's HospitalSource

- [A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (ATHOS-3)](https://clinicaltrials.gov/ct2/show/NCT02338843) & [Expanded Access for LJPC-501](https://clinicaltrials.gov/ct2/show/NCT03245528) (2015-2018)

Partner with Right2Hope

Right2Hope helps sponsors translate regulatory programs into actionable patient access pathways. Connect with our team to publish new programs, streamline intake workflows, or align with providers seeking compassionate use options.

Talk to Our Team→Explore Programs